CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 13 enrolled
Drug / intervention
Hypertonic Salinedrug
Likely dose
Hypertonic Saline 5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00753987
NCT00753987Phase 1Completed
CompareCT.gov

Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis

The Hospital for Sick Children·interventional·Posted Sep 17, 2008·Updated Feb 13, 2025

In Brief

A Phase 1 clinical trial evaluating Hypertonic Saline for Cystic Fibrosis. Completed, enrolled 13 participants across 1 site.

Detailed Summary

The objective of the study is to determine whether or not inhalation of hypertonic saline will be tolerated by infants with cystic fibrosis and the effect of inhalation on their lung function.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis
CountriesCanada
Collaborators--

Timeline

Phase 1CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 17, 2008
Enrollment StartMar 1, 2006
Primary CompletionJul 1, 2006
Study CompletionJan 1, 2007
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.8 years ago

Interventions

Hypertonic Salinedrug

5 ml of 7% saline will be administered via mask with Pari LC Plus nebuliser and a Pari Ultra Ned compressor.